Cargando…
Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity
BACKGROUND: HER2 gene copy status, and concomitant administration of trastuzumab (Herceptin), remains one of the best examples of targeted cancer therapy based on understanding the genomic etiology of disease. However, newly diagnosed breast cancer cases with equivocal HER2 results present a challen...
Autores principales: | Gunn, Shelly, Yeh, I-Tien, Lytvak, Irina, Tirtorahardjo, Budi, Dzidic, Natasha, Zadeh, Soheila, Kim, Jaeweon, McCaskill, Chris, Lim, Lony, Gorre, Mercedes, Mohammed, Mansoor |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915985/ https://www.ncbi.nlm.nih.gov/pubmed/20667129 http://dx.doi.org/10.1186/1471-2407-10-396 |
Ejemplares similares
-
Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer
por: Gunn, Shelly, et al.
Publicado: (2013) -
The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas
por: Ji, Hongfei, et al.
Publicado: (2015) -
Insulinoma with equivocal imaging
por: Belabed, Wafa, et al.
Publicado: (2023) -
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy
por: Crespo, James, et al.
Publicado: (2020) -
Observations in Support of Equivocal Generation
Publicado: (1811)